Top Markets
#1 Threshold Network Threshold Network +62.22%
#2 TENDIES TENDIES +59.58%
#3 Cash Cat Cash Cat +20.67%
#4 OSK OSK +15.99%
#5 Magma Finance Magma Finance +13.45%
#6 Ape and Pepe Ape and Pepe +12.62%
#7 Kite Kite +11.97%
#8 Falcon Finance Falcon Finance +11.18%
#9 Asteroid Shiba Asteroid Shiba +10.17%
#10 Maple Finance Maple Finance +10.08%
Coin of the day
Threshold Network Threshold Network
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Invivyd, Inc. Invivyd, Inc.

Invivyd, Inc.

IVVD
Peringkat dalam Saham #17261
Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development... Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development phase, operates within the United States, specializing in the discovery, progression, and marketing of antibody-derived solutions for infectious diseases. The company's leading drug candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical investigation for both the management and prevention of coronavirus disease. Adagio Therapeutics maintains collaborative agreements with Adimab, LLC to facilitate the identification and enhancement of its exclusive antibodies. Furthermore, it partners with the Scripps Research Institute to conduct studies aimed at uncovering potential vaccine solutions for the prophylaxis, detection, or therapy of influenza or beta coronaviruses. Incorporated in 2020, the company's base of operations is in Waltham, Massachusetts.
Harga Saham
$0.8502
Terakhir disinkronkan: 2026-09-01
Kapitalisasi Pasar
$250.47M
Perubahan (1 hari)
-10.96%
Perubahan (1 tahun)
-17.46%
Negara
US
Perdagangan Invivyd, Inc. (IVVD)

Kategori

Healthcare
Laba untuk Invivyd, Inc. (IVVD)
Laba pada 2026 TTM: 0
Menurut laporan keuangan terbaru dari Invivyd, Inc., laba saat ini perusahaan adalah 0. Pada tahun 2026, perusahaan memperoleh laba sebesar 0, sama dengan laba tahun 2026 sebesar 0. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Invivyd, Inc. dari 2026 hingga 2026
Laba pada akhir setiap tahun
Tahun Laba Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Laba untuk perusahaan serupa atau pesaing
Perusahaan Laba Perbedaan Laba Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH